Central pain as a manifestation of partial epileptic seizures.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 10204761)

Published in Pain on March 01, 1999

Authors

J Scholz1, P Vieregge, A Moser

Author Affiliations

1: Department of Neurology, Medical University of Lübeck, Germany. scholz_j@neuro.mu-lubeck.de

Articles citing this

Painful seizures associated with a lesion in the midcingulate cortex. J Neurol (2009) 0.81

Articles by these authors

Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J Clin Invest (1996) 2.68

Mutations in the PTS1 receptor gene, PXR1, define complementation group 2 of the peroxisome biogenesis disorders. Nat Genet (1995) 2.62

Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata. Nat Genet (1997) 2.13

Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany. Neurology (1996) 2.01

Leptin deficiency enhances sensitivity to endotoxin-induced lethality. Am J Physiol (1999) 1.90

Epidemiologic study of 203 sibling pairs with Parkinson's disease: the GenePD study. Neurology (2002) 1.90

A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat Genet (1998) 1.84

DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease. Neurology (2004) 1.83

Transdermal nicotine in PD: a randomized, double-blind, placebo-controlled study. Neurology (2001) 1.71

Effects of ENU dosage on mouse strains. Mamm Genome (2000) 1.69

Diet and Parkinson's disease. II: A possible role for the past intake of specific nutrients. Results from a self-administered food-frequency questionnaire in a case-control study. Neurology (1996) 1.68

Genetic and phenotypic heterogeneity in disorders of peroxisome biogenesis--a complementation study involving cell lines from 19 patients. Pediatr Res (1989) 1.67

Clinical and biochemical spectrum of patients with RSH/Smith-Lemli-Opitz syndrome and abnormal cholesterol metabolism. Am J Med Genet (1997) 1.56

Rhizomelic chondrodysplasia punctata and survival beyond one year: a review of the literature and five case reports. Clin Genet (1990) 1.47

Mutations in the gene encoding 3 beta-hydroxysteroid-delta 8, delta 7-isomerase cause X-linked dominant Conradi-Hünermann syndrome. Nat Genet (1999) 1.47

Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene. Ann Neurol (2001) 1.42

Developmental regulation of creatine kinase gene expression by myogenic factors in embryonic mouse and chick skeletal muscle. Development (1991) 1.41

Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: expanding the phenotype. Ann Neurol (2000) 1.40

High mutation rate in dopa-responsive dystonia: detection with comprehensive GCHI screening. Neurology (2005) 1.34

Standardization of complementation grouping of peroxisome-deficient disorders and the second Zellweger patient with peroxisomal assembly factor-1 (PAF-1) defect. Am J Hum Genet (1993) 1.29

Reduced leptin levels in starvation increase susceptibility to endotoxic shock. Am J Pathol (2000) 1.25

Genome-wide scan for Parkinson's disease: the GenePD Study. Neurology (2001) 1.25

A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism. Neurology (1999) 1.25

Impaired membrane traffic in defective ether lipid biosynthesis. Hum Mol Genet (2001) 1.22

Novel mutation in the TOR1A (DYT1) gene in atypical early onset dystonia and polymorphisms in dystonia and early onset parkinsonism. Neurogenetics (2001) 1.18

Abnormal sterol metabolism in patients with Conradi-Hünermann-Happle syndrome and sporadic lethal chondrodysplasia punctata. Am J Med Genet (1999) 1.15

Mutations in DYT1: extension of the phenotypic and mutational spectrum. Neurology (2004) 1.15

[Bilateral pheochromocytoma associated with duodeno-jejunal GIST in patient with von Recklinghausen disease: report of a clinical case]. Chir Ital (2001) 1.10

Multianalyte profiling of serum cytokines for detection of pancreatic cancer. Cancer Biomark (2005) 1.10

Effects of dyskinesias in Parkinson's disease on quality of life and health-related costs: a prospective European study. Eur J Neurol (2005) 1.09

Low cerebrospinal fluid insulin levels in obese humans. Diabetologia (2006) 1.08

Different types of repeat expansion in the TATA-binding protein gene are associated with a new form of inherited ataxia. Eur J Hum Genet (2001) 1.08

Biochemical abnormalities in rhizomelic chondrodysplasia punctata. J Pediatr (1988) 1.08

German-Canadian family (family A) with parkinsonism, amyotrophy, and dementia - Longitudinal observations. Parkinsonism Relat Disord (1997) 1.06

Search for mediators of the lipogenic effects of tumor necrosis factor: potential role for interleukin 6. Cancer Res (1990) 1.05

Exclusion of chromosome regions 6p12 and 15q11, but not chromosome region 7p11, in a German family with autosomal dominant congenital nystagmus. Genomics (1998) 1.04

Monocyte induction of IL-10 and down-regulation of IL-12 by iC3b deposited in ultraviolet-exposed human skin. J Immunol (1998) 1.02

A case of glycine-receptor antibody-associated encephalomyelitis with rigidity and myoclonus (PERM): clinical course, treatment and CSF findings. J Neurol (2011) 1.02

Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study. Mov Disord (2005) 1.01

Discordant twins with Parkinson's disease: positron emission tomography and early signs of impaired cognitive circuits. Ann Neurol (1994) 1.00

The peroxisome deficient PEX2 Zellweger mouse: pathologic and biochemical correlates of lipid dysfunction. J Mol Neurosci (2001) 0.99

Role of mitochondria in Parkinson disease. Biol Chem (1999) 0.98

Personality traits in young patients with Parkinson's disease. Acta Neurol Scand (2001) 0.97

Epidemiology of multiple system atrophy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms. Neurol Sci (2001) 0.96

A fibroblast cell line defective in alkyl-dihydroxyacetone phosphate synthase: a novel defect in plasmalogen biosynthesis. Proc Natl Acad Sci U S A (1997) 0.95

Late-onset metachromatic leukodystrophy: genotype strongly influences phenotype. Neurology (2006) 0.95

Diet and Parkinson's disease. I: A possible role for the past intake of specific foods and food groups. Results from a self-administered food-frequency questionnaire in a case-control study. Neurology (1996) 0.94

Effect of interleukin-1 on lipid metabolism in the rat. Similarities to and differences from tumor necrosis factor. Arterioscler Thromb (1991) 0.94

The importance of gene dosage studies: mutational analysis of the parkin gene in early-onset parkinsonism. Hum Mol Genet (2001) 0.93

Developmentally regulated expression of three slow isoforms of myosin heavy chain: diversity among the first fibers to form in avian muscle. Dev Biol (1992) 0.92

A new genus and species of Euptychiina (Lepidoptera: Nymphalidae: Satyrinae) from southern Brazil. Neotrop Entomol (2011) 0.92

Induction of UCP2 gene expression by LPS: a potential mechanism for increased thermogenesis during infection. Biochem Biophys Res Commun (1998) 0.92

LPS-induced anorexia in leptin-deficient (ob/ob) and leptin receptor-deficient (db/db) mice. Am J Physiol (1997) 0.92

The peroxin Pex6p gene is impaired in peroxisomal biogenesis disorders of complementation group 6. J Hum Genet (2001) 0.91

Refinement of the spinocerebellar ataxia type 4 locus in a large German family and exclusion of CAG repeat expansions in this region. J Neurol (2003) 0.91

Phenotypic variability in siblings with Farber disease. J Pediatr (1984) 0.90

A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD study. Neurology (2003) 0.90

Rhizomelic chondrodysplasia punctata type 1: report of mutations in 3 children from India. J Appl Genet (2010) 0.90

BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study. Neurology (2005) 0.90

Medium-chain versus long-chain triacylglycerol emulsion hydrolysis by lipoprotein lipase and hepatic lipase: implications for the mechanisms of lipase action. Biochemistry (1990) 0.89

Genetic testing for early-onset torsion dystonia (DYT1): introduction of a simple screening method, experiences from testing of a large patient cohort, and ethical aspects. Genet Test (1999) 0.89

Microbiological spectrum and susceptibility patterns of pathogens causing bacteraemia in paediatric febrile neutropenic oncology patients: comparison between two consecutive time periods with use of different antibiotic treatment protocols. Int J Antimicrob Agents (2005) 0.89

Mutants in a macrophage-like cell line are defective in plasmalogen biosynthesis, but contain functional peroxisomes. J Biol Chem (1992) 0.89

The effect of LXR activators on AP-1 proteins in keratinocytes. J Invest Dermatol (2004) 0.89

Focal and segmental primary dystonia in north-western Germany--a clinico-genetic study. Acta Neurol Scand (2003) 0.89

Sexuality in young patients with Parkinson's disease: a population based comparison with healthy controls. J Neurol Neurosurg Psychiatry (2000) 0.88

PEX7 gene structure, alternative transcripts, and evidence for a founder haplotype for the frequent RCDP allele, L292ter. Genomics (2000) 0.88

Acute jejunal ileus in intestinal lymphangiectasia. Clin Investig (1993) 0.88

Attitudes of young patients with Parkinson's disease towards possible presymptomatic and prenatal genetic testing. Genet Couns (2001) 0.88

Generalized cowpox infection in a patient with Darier disease. Br J Dermatol (2011) 0.87

Parkinsonism in multiple sclerosis. Mov Disord (1992) 0.87

Cholesterol sulfate stimulates involucrin transcription in keratinocytes by increasing Fra-1, Fra-2, and Jun D. J Lipid Res (2001) 0.86

Interferon-alpha and ribavirin in treating children and young adults with chronic hepatitis C after malignancy. Pediatrics (2000) 0.86

Effects of amantadine treatment on in vitro production of interleukin-2 in de-novo patients with idiopathic Parkinson's disease. J Neuroimmunol (1999) 0.86

Regulation of microsomal triglyceride transfer protein mRNA expression by endotoxin and cytokines. J Lipid Res (1998) 0.86

Neuronal electrical high frequency stimulation enhances GABA outflow from human neocortical slices. Neurochem Int (2006) 0.85

Paraneoplastic opsoclonus-myoclonus syndrome in metastatic ovarian carcinoma. J Neurol Neurosurg Psychiatry (1994) 0.85

[Appendiceal mucocele associated with colonic neoplasm. Report of 2 cases and review of the literature]. Chir Ital (2001) 0.85

Tumor necrosis factor-increased hepatic very-low-density lipoprotein production and increased serum triglyceride levels in diabetic rats. Diabetes (1990) 0.85

Neurology of adult alpha-mannosidosis. J Neurol Neurosurg Psychiatry (1996) 0.85

Prenatal diagnosis of malignant osteopetrosis in Bedouin families by linkage analysis. Prenat Diagn (2001) 0.84

Feasibility of high-dose interleukin-2 in heavily pretreated pediatric cancer patients. Ann Oncol (2005) 0.84

Evaluation of the role of the D2 dopamine receptor in myoclonus dystonia. Ann Neurol (2000) 0.84

Lipid infusion with different triglyceride cores (long-chain vs medium-chain/long-chain triglycerides): effect on plasma lipids and bilirubin binding in premature infants. JPEN J Parenter Enteral Nutr (1992) 0.84

Differentiation of parkinsonian syndromes according to differences in executive functions. J Neural Transm (Vienna) (2003) 0.84

A study of visual hallucinations in patients with Parkinson's disease. J Neurol (1997) 0.83

Stride parameters in healthy young and old women--measurement variability on a simple walkway. Exp Aging Res (2000) 0.83

Structured triacylglycerol emulsion, containing both medium- and long-chain fatty acids, in long-term home parenteral nutrition: a double-blind randomized cross-over study. Nutrition (2000) 0.83

Post renal transplantation human herpesvirus 8-associated lymphoproliferative disorder and Kaposi's sarcoma. Br J Haematol (2001) 0.83

Zellweger syndrome amniocytes: morphological appearance and a simple sedimentation method for prenatal diagnosis. Pediatr Res (1988) 0.83

Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD Study. Neurology (2006) 0.83

Electrical high frequency stimulation of the caudate nucleus induces local GABA outflow in freely moving rats. J Neurosci Methods (2006) 0.83

On the reasons for the delay of P3 latency in healthy elderly subjects. Electroencephalogr Clin Neurophysiol (1991) 0.82

Small intestinal fatty acid synthesis is increased in diabetic rats. Endocrinology (1990) 0.82

Blood- and skin-derived monocytes/macrophages respond to C3a but not to C3a(desArg) with a transient release of calcium via a pertussis toxin-sensitive signal transduction pathway. Eur J Immunol (1997) 0.82

Synthesis, pharmacologic activity, and structure-activity relationships of a series of propafenone-related modulators of multidrug resistance. J Med Chem (1995) 0.82

Smoking and Parkinson's disease: a case-control study in Germany. Int J Epidemiol (1997) 0.82

Smoking habits in multiple system atrophy and progressive supranuclear palsy. European Study Group on Atypical Parkinsonisms. Neurology (2000) 0.81

Familial glioma: occurrence within the "familial cancer syndrome" and systemic malformations. J Neurol (1987) 0.81